Lonza Joins DSM as Manufacturer of Biopharma Drug for Agennix

09:55 AM | April 12, 2012 | Alex Scott

Lonza has agreed to supply Agennix (Heidelberg, Germany), a biotech firm, with commercial quantities of talactoferrin, Agennix’s trial drug for the treatment of non-small cell lung cancer (NSCLC). As...